Volume 2, Issue 2 (May 2017)                   JNFS 2017, 2(2): 139-140 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Eslami O. Dark Chocolate and Metabolic Syndrome; Do Polyphenols All that Matter?. JNFS 2017; 2 (2) :139-140
URL: http://jnfs.ssu.ac.ir/article-1-60-en.html
Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran
Full-Text [PDF 234 kb]   (870 Downloads)     |   Abstract (HTML)  (3229 Views)
Full-Text:   (570 Views)
 
Dark Chocolate and Metabolic Syndrome; Do Polyphenols All that Matter?

 
Omid Eslami; MSc
 
Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
 
ARTICLE INFO
LETTER TO THE EDITOR    
*Corresponding Author:
Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Tehran, Iran.
eslami.iums@gmail.com
 
Postal code: 1449614535
Tel: +98 9336054861
 
Article history:
Received: 25 Nov 2016
Revised: 30 Dec 2016
Accepted: 10 Jan 2017
 
 
The prevalence of cardiovascular diseases is considerably high among individuals with metabolic syndrome (MetS). Establishment of dietary interventions that prevent the development of cardiovascular risk factors in this high-risk group seems crucial. With this regard, study conducted by Mozaffari-Khosravi & colleagues (Mozaffari-Khosravi et al., 2016) is welcomed. The researchers showed that daily consumption of two different servings of dark chocolate (DC) for eight weeks had no beneficial effect on blood pressure and oxidative stress in patients with MetS. They compared their findings with other studies based on differences in servings of DCs and their polyphenolic content.
Current evidences on the anti-inflammatory and antihypertensive properties of DC mainly focus on its polyphenolic content. Although the possible role of magnesium which is found in high amounts in DC (327 mg/100g DC) was missed in the present study as well as most of the previous studies. An inverse correlation was reported between dietary magnesium intakes with risk of MetS (Sarrafzadegan et al., 2016). Moreover, previous clinical trials have shown favorable effects of magnesium supplementation on blood pressure which might be related to its role in reducing systemic inflammation, improving glycemic status, and vasorelaxation (Rodriguez-Moran and Guerrero-Romero, 2014, Rosanoff and Plesset, 2013).
Recently, a meta-analysis showed that supplementation with magnesium at a dose of 300 mg/day can elevate serum levels and decrease blood pressure (Zhang et al., 2016). Thus, it is expected that a 100-g bar of DC could have beneficial effects on blood pressure as it was already confirmed by Grassi et al., study (Grassi et al., 2005). They showed that consumption of 100 g DC for 15 days significantly reduced blood pressure in patients with essential hypertension.
In short, health benefits of DC consumption on cardiovascular system should be interpreted in the context of both polyphenols and magnesium. It would had been noteworthy if researchers had reported the magnesium content of DC, dietary intake of magnesium throughout the study, and changes in serum levels of magnesium to determine whether magnesium in DC could
affect the study parameters. However, due to
the consumption of low servings of DC in this study, the positive effects of both polyphenols and magnesium might not be clinically evident.
 
References
Grassi D, et al. 2005. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension. 46 (2): 398-405.
Mozaffari-Khosravi H, Naghdipour-Biregani A, Zavar-Reza J & Poursoleiman F 2016. The Effects of Dark Chocolate Consumption on Oxidative Stress and Blood Pressure in Patients with Metabolic Syndrome: a Randomized Clinical Trial. Journal of nutrition and food security. 1 (1): 1-8.
Rodriguez-Moran M & Guerrero-Romero F 2014. Oral magnesium supplementation improves the metabolic profile of metabolically obese, normal-weight individuals: a randomized double-blind placebo-controlled trial. Archives of medical research. 45 (5): 388-393.
Rosanoff A & Plesset MR 2013. Oral magnesium supplements decrease high blood pressure (SBP>155 mmHg) in hypertensive subjects on anti-hypertensive medications: a targeted meta-analysis. Magnesium research. 26 (3): 93-99.
Sarrafzadegan N, Khosravi-Boroujeni H, Lotfizadeh M, Pourmogaddas A & Salehi-Abargouei A 2016. Magnesium status and the metabolic syndrome: A systematic review and meta-analysis. Nutrition (Burbank, Los Angeles County, Calif.). 32 (4): 409-417.
Zhang X, et al. 2016. Effects of magnesium supplementation on blood pressure: a meta-analysis of randomized double-blind placebo-controlled trials. Hypertension. 68: 324–333.
 

 
Type of article: letter to the editor | Subject: public specific
Received: 2016/11/25 | Published: 2017/05/1 | ePublished: 2017/05/1

References
1. Grassi D, et al. 2005. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension. 46 (2): 398-405.
2. Mozaffari-Khosravi H, Naghdipour-Biregani A, Zavar-Reza J & Poursoleiman F 2016. The Effects of Dark Chocolate Consumption on Oxidative Stress and Blood Pressure in Patients with Metabolic Syndrome: a Randomized Clinical Trial. Journal of nutrition and food security. 1 (1): 1-8.
3. Rodriguez-Moran M & Guerrero-Romero F 2014. Oral magnesium supplementation improves the metabolic profile of metabolically obese, normal-weight individuals: a randomized double-blind placebo-controlled trial. Archives of medical research. 45 (5): 388-393.
4. Rosanoff A & Plesset MR 2013. Oral magnesium supplements decrease high blood pressure (SBP>155 mmHg) in hypertensive subjects on anti-hypertensive medications: a targeted meta-analysis. Magnesium research. 26 (3): 93-99.
5. Sarrafzadegan N, Khosravi-Boroujeni H, Lotfizadeh M, Pourmogaddas A & Salehi-Abargouei A 2016. Magnesium status and the metabolic syndrome: A systematic review and meta-analysis. Nutrition (Burbank, Los Angeles County, Calif.). 32 (4): 409-417.
6. Zhang X, et al. 2016. Effects of magnesium supplementation on blood pressure: a meta-analysis of randomized double-blind placebo-controlled trials. Hypertension. 68: 324–333.

Add your comments about this article : Your username or Email:
CAPTCHA

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 3.0 | Journal of Nutrition and Food Security

Designed & Developed by : Yektaweb